More about
Autosomal-Dominant, Progressive Neuromuscular Disease
News
March 06, 2024
2 min read
Save
Treatment with antibody oligonucleotide conjugate led to improved outcomes in DM1
Long-term treatment with IV administration of a novel therapeutic for those with myotonic dystrophy type 1 led to significant improvement in muscle strength and control and improved quality of life, data show.